{"id":61336,"date":"2025-05-29T10:03:14","date_gmt":"2025-05-29T08:03:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/diagnostics-ai-launches-industrys-first-ce-ivdr-certified-transparent-ai-platform-for-molecular-diagnostics-as-regulatory-deadlines-take-effect\/"},"modified":"2025-05-29T10:03:14","modified_gmt":"2025-05-29T08:03:14","slug":"diagnostics-ai-launches-industrys-first-ce-ivdr-certified-transparent-ai-platform-for-molecular-diagnostics-as-regulatory-deadlines-take-effect","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/diagnostics-ai-launches-industrys-first-ce-ivdr-certified-transparent-ai-platform-for-molecular-diagnostics-as-regulatory-deadlines-take-effect\/","title":{"rendered":"Diagnostics.ai Launches Industry’s First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect"},"content":{"rendered":"
\n

\nCE-marked under the EU IVDR regulation, Diagnostics.ai’s platform is the first to deliver algorithmic transparency and per-test auditability for clinical PCR diagnostics<\/i><\/p>\n

<\/a>
<\/a><\/p>\n

LONDON–(BUSINESS WIRE)–#AI<\/a>—Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI<\/b><\/p>\n

\nAs the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai<\/b> launches the industry\u2019s first fully-transparent machine learning platform for clinical real-time PCR diagnostics \u2013 demonstrating exactly how each result was achieved, a first for molecular-testing machine learning. The technology is backed by over 15 years of experience and millions of successfully processed samples with >99.9% proven accuracy.<\/p>\n

\nThe CE-IVDR Strategic Advantage Platform is Diagnostics.ai’s response to the new wave of stringent EU regulations under the In Vitro Diagnostic Medical Devices Regulation (IVDR), which demand heightened standards for diagnostic accuracy, reproducibility, and algorithm transparency.<\/p>\n

\n\u201cWhile most diagnostic algorithms remain an impenetrable \u2018black box,\u2019 the PCR.AI API was engineered with transparency included from the ground up,\u201d <\/i>said Aron Cohen, Chief Executive Officer of Diagnostics.ai. \u201cOur platform delivers transparency and traceability that meet and support the highest standards set by CE-IVDR, making the AI decision-making process visible, understandable, and traceable.\u201d<\/i><\/p>\n

\nKey Innovations of the Transparent AI Architecture<\/b><\/p>\n

\nPCR.AI\u2019s platform is built around a pioneering \u201cmodel-aware\u201d architecture, enabling laboratories to understand the suggestions that the AI makes.<\/p>\n

\nHighlighted Benefits:<\/p>\n